Tilray Brands (NASDAQ:TLRY) Shares Down 3.7% – Here’s What Happened

Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell 3.7% during trading on Thursday . The stock traded as low as $6.93 and last traded at $6.95. 2,415,825 shares traded hands during trading, a decline of 39% from the average session volume of 3,978,633 shares. The stock had previously closed at $7.22.

Key Tilray Brands News

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray Pharma announced a strategic alliance with Tilray Medical, CC Pharma, 14U Pharma and the “gesund leben” cooperation (operated by Alliance Healthcare Deutschland) to expand pharmacy distribution across Germany — access to Alliance’s network (27 logistics centers, >10,000 pharmacies) could accelerate prescription and OTC pharmaceutical sales in a large EU market and reduce go‑to‑market friction. Article Title
• Positive Sentiment: Tilray’s beverage arm expanded its product lineup with Pub Light, a 99-calorie, 4% ABV light lager under the Pub Beer/Cheap Fun banner — product innovation and broader SKU presence support on‑premise and retail distribution growth in the U.S. beverage segment and help diversify revenue away from cannabis alone, though near‑term sales impact will be modest. Article Title
• Neutral Sentiment: Brokerages maintain a consensus “Hold” rating on TLRY, signaling analyst caution and limited near‑term upside despite recent operational announcements; this can mute investor reaction to positive commercial news until revenue and margin improvements become clearer. Article Title

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Roth Mkm lowered their price objective on shares of Tilray Brands from $20.00 to $10.00 and set a “neutral” rating for the company in a research report on Tuesday, January 20th. ATB Cormark Capital Markets raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 10th. Canaccord Genuity Group started coverage on Tilray Brands in a research note on Tuesday, January 27th. They issued a “hold” rating on the stock. Wall Street Zen lowered Tilray Brands from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $13.33.

Tilray Brands Price Performance

The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.72 and a current ratio of 2.81. The company has a fifty day moving average price of $8.18 and a two-hundred day moving average price of $10.87. The company has a market cap of $809.74 million, a P/E ratio of -0.31 and a beta of 1.96.

Tilray Brands (NASDAQ:TLRY) last released its earnings results on Thursday, January 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.12. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The business had revenue of $217.51 million for the quarter, compared to analyst estimates of $211.15 million. During the same quarter in the prior year, the company posted ($0.03) earnings per share. On average, sell-side analysts anticipate that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tilray Brands

Several large investors have recently made changes to their positions in TLRY. Optiver Holding B.V. increased its stake in shares of Tilray Brands by 239.4% during the 3rd quarter. Optiver Holding B.V. now owns 224,049 shares of the company’s stock worth $388,000 after purchasing an additional 158,041 shares during the last quarter. Cresset Asset Management LLC increased its position in Tilray Brands by 72.1% during the third quarter. Cresset Asset Management LLC now owns 501,989 shares of the company’s stock worth $868,000 after buying an additional 210,267 shares during the last quarter. Quinn Opportunity Partners LLC raised its stake in Tilray Brands by 11.6% in the second quarter. Quinn Opportunity Partners LLC now owns 1,918,080 shares of the company’s stock valued at $795,000 after buying an additional 200,000 shares during the period. Bogart Wealth LLC raised its stake in Tilray Brands by 203.2% in the third quarter. Bogart Wealth LLC now owns 31,111 shares of the company’s stock valued at $54,000 after buying an additional 20,850 shares during the period. Finally, SLT Holdings LLC acquired a new stake in shares of Tilray Brands in the third quarter valued at approximately $178,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.